IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Plasmablastic Lymphoma
National Cancer Institute (NCI)monoclonal_antibodyPhase 2Active
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 55/ 100
- Competitive Position
- 81/ 100
Competitive context
23 Active assets in the Plasmablastic Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PREDNISONE TABLETS National Cancer Institute (NCI) | Phase 2 | BB |
Inno-206 National Cancer Institute (NCI) | Phase 2 | BB |
ETOPOSIDE National Cancer Institute (NCI) | Phase 2 | BB |
(+)-VINCRISTINE National Cancer Institute (NCI) | Phase 2 | BB |
Cyclophosphamide National Cancer Institute (NCI) | Phase 2 | BB |
View all 27 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →